// App-Quantinova.ai

: Posterior Reversible Encephalopathy Syndrome: A Rare Side Effect of Nivolumab

Researchers

Presenter

  • Muhammad Shan Ul Abedin

Principal Investigators

  • Maria Khan

  • Bikash Basyal

Medical Centers

  • Abington Memorial Hospital, Abington, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Oncology (ONC)

Disease

  • Posterior Reversible Encephalopathy Syndrome

  • Esophageal Cancer

  • Brain metastasis

  • Encephalopathy

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Fluorouracil

  • Adrucil injection

  • L-leucovorin

  • Oxaliplatin

  • Lisinopril

  • Cipril

  • Prednisone

  • Nivolumab

  • Levetiracetam

  • Oxaliplatin, 5-fluorouracil and folic acid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved